ProgenaBiome   Report issue

For profit Phase 1 Phase 2
Founded: Ventura CA United States (2018)
Status: No NME R&D (2018)

Organization Overview

First Clinical Trial
2020
NCT04335084
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

ProgenaBiome